Ocugen, Inc. (NASDAQ: OCGN) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye. The company’s Phase 3 small molecule drug candidate for oGVHD, if approved, will be the first and only treatment for this orphan disease. Ocugen’s breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many”. And its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.
For more information on the company, visit www.ocugen.com
To view IBN’s virtual coverage of the 32nd Annual ROTH Conference, visit http://www.ibn.fm/ROTH2020
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies invited to participate at the 32nd Annual ROTH Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the virtualization of ROTH’s main event.
IBN has provided real-time coverage for ROTH events through its various brands, social media accounts and investment newsletters for more than a decade. ROTH conferences are premier gatherings with an outstanding reputation for being among the best investor-oriented events. To further expand visibility of each participating company and ensure another successful year, IBN’s syndication partners are extending the virtual coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
About InvestorBrandNetwork
The InvestorBrandNetwork consists of financial brands introduced to the investment public over the course of 14+ years. With IBN, we have amassed a collective audience of 1+ million social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of Client Partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]